Literature DB >> 11832465

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

William J Sandborn1, Brian G Feagan, Stephen B Hanauer, Herbert Lochs, Robert Löfberg, Robert Modigliani, Daniel H Present, Paul Rutgeerts, Jurgen Schölmerich, Eduard F Stange, Lloyd R Sutherland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11832465     DOI： 10.1053/gast.2002.31072

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  149 in total

Review 1.  Biopsy assessment of drug efficacy in the gastrointestinal tract.

Authors:  Marjorie M Walker
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

Review 2.  Assessing disease activity and disease activity indices for inflammatory bowel disease.

Authors:  Feng Xiao Li; Lloyd R Sutherland
Journal:  Curr Gastroenterol Rep       Date:  2002-12

Review 3.  Evaluation of new therapies for inflammatory bowel disease.

Authors:  E Carty; D S Rampton
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

4.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  M J Carter; A J Lobo; S P L Travis
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

5.  How to read a clinical trial paper: a lesson in basic trial statistics.

Authors:  Shail M Govani; Peter D R Higgins
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-04

6.  Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.

Authors:  Eun Soo Kim; Won Ho Kim
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

Review 7.  Mucosal healing in inflammatory bowel disease: where do we stand?

Authors:  Christina Ha; Asher Kornbluth
Journal:  Curr Gastroenterol Rep       Date:  2010-12

Review 8.  Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.

Authors:  Britt Christensen; David T Rubin
Journal:  Curr Gastroenterol Rep       Date:  2016-01

9.  Randomized controlled trial: moxibustion and acupuncture for the treatment of Crohn's disease.

Authors:  Chun-Hui Bao; Ji-Meng Zhao; Hui-Rong Liu; Yuan Lu; Yi-Fang Zhu; Yin Shi; Zhi-Jun Weng; Hui Feng; Xin Guan; Jing Li; Wei-Feng Chen; Lu-Yi Wu; Xiao-Ming Jin; Chuan-Zi Dou; Huan-Gan Wu
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

10.  Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale.

Authors:  Bijal Surti; Brennan Spiegel; Andrew Ippoliti; Eric A Vasiliauskas; Peter Simpson; David Q Shih; Stephan R Targan; Dermot P B McGovern; Gil Y Melmed
Journal:  Dig Dis Sci       Date:  2012-12-19       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.